| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |